Evidence map›Paper›PMID 22759506›Full record

ArticleEnvironmental health : a global access science source2012

Policy relevant results from an expert elicitation on the health risks of phthalates.

Karin Elisabeth Zimmer, Arno Christian Gutleb, Solveig Ravnum, Martin Krayer von Krauss, Albertinka J Murk, Erik Ropstad, Janneche Utne Skaare, Gunnar Sundstøl Eriksen, Jan Ludvig Lyche, Janna G Koppe and 4 more

Abstract readEvaluation Study
In one paragraph

Article in Environmental health : a global access science source, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. A perspective on the potential risks of emerging contaminants to human and environmental health.Environmental science and pollution research international · 2015
    Review
  3. Article
  4. Nanoparticles in the environment: assessment using the causal diagram approach.Environmental health : a global access science source · 2012
    Review
  5. Article
  6. Application of social media in the environment and health professional community.Environmental health : a global access science source · 2012
    Article
  7. How can scientists bring research to use: the HENVINET experience.Environmental health : a global access science source · 2012
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Karin Elisabeth ZimmerDepartment of Basic Sciences and Aquatic Medicine, Norwegian School of Veterinary Science, PO Box 8146, 0033 Oslo, Norway. karin.zimmer@nvh.no
Arno Christian Gutleb
Solveig Ravnum
Martin Krayer von Krauss
Albertinka J Murk
Erik Ropstad
Janneche Utne Skaare
Gunnar Sundstøl Eriksen
Jan Ludvig Lyche
Janna G Koppe
Brooke L Magnanti
Aileen Yang
Alena Bartonova
Hans Keune

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe EU 6th Framework Program (FP)-funded Health and Environment Network (HENVINET) aimed to support informed policy making by facilitating the availability of relevant knowledge on different environmental health issues. An approach was developed by which scientific agreement, disagreement, and knowledge gaps could be efficiently identified, and expert advice prepared in a way that is usable for policy makers. There were two aims of the project: 1) to apply the tool to a relevant issue; the potential health impacts of the widely used plasticizers, phthalates, and 2) to evaluate the method and the tool by asking both scientific experts and the target audience, namely policy makers and stakeholders, for their opinions.

methodsThe tool consisted of an expert consultation in several steps on the issue of phthalates in environmental health. A diagram depicting the cause-effect chain, from the production and use of phthalates to potential health impacts, was prepared based on existing reviews. This was used as a basis for an online questionnaire, through which experts in the field were consulted. The results of this first round of consultation laid the foundation for a new questionnaire answered by an expert panel that, subsequently, also discussed approaches and results in a workshop. One major task of the expert panel was to pinpoint priorities from the cause-effect chain according to their impact on the extent of potential health risks and their relevance for reducing uncertainty. The results were condensed into a policy brief that was sent to policy makers and stakeholders for their evaluation.

resultsThe experts agreed about the substantial knowledge gaps within the field of phthalates. The top three priorities for further research and policy action were: 1) intrauterine exposure, 2) reproductive toxicology, and 3) exposure from medical devices. Although not all relevant information from the cause-effect chain is known for phthalates, most experts thought that there are enough indications to justify a precautionary approach and to restrict their general use. Although some of the experts expressed some scepticism about such a tool, most felt that important issues were highlighted.

conclusionsThe approach used was an efficient way at summarising priority knowledge gaps as a starting point for health risk assessment of compounds, based on their relevance for the risk assessment outcome. We conclude that this approach is useful for supporting policy makers with state-of-the-art scientific knowledge weighed by experts. The method can assist future evidence-based policy making.

Indexed as

Environmental ExposureEnvironmental PolicyAnimalsEnvironmental HealthEnvironmental PollutantsHumansPhthalic AcidsPolicy MakingRisk AssessmentSurveys and QuestionnairesEnvironmental PollutantsPhthalic Acids

Identifiers

PMID22759506
PMCPMC3388473

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.